Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Biosci Biotechnol Biochem ; 85(6): 1476-1484, 2021 May 25.
Article in English | MEDLINE | ID: mdl-33720315

ABSTRACT

Formation of taste-active pyroglutamyl (pGlu) peptide ethyl esters in sake was investigated: 2 enzymes (A and B) responsible for the esterification were purified from a rice koji extract. MADLI-TOF/TOF analysis after deglycosylation identified enzyme (A) as peptidase S28 (GenBank accession number OOO13707.1) and enzyme (B) as serine-type carboxypeptidase (accession number AO090010000534). Both enzymes hydrolyzed pGlu peptides and formed ethyl esters under sake mash conditions: acidic pH (3-4) and in ethanol (5%-20% v/v) aqueous solutions. Enzyme (A) formed pGlu penta-peptide ethyl esters from pGlu undeca-peptides by a prolyl endo-type reaction. Enzyme (B) formed (pGlu) deca-peptide and its ethyl esters from pGlu undeca-peptides in an exo-type reaction. We are the first to report the enzymatic ethyl esterification reaction in the formation of pGlu peptides by rice koji peptidases.


Subject(s)
Esters/chemistry , Oryza/enzymology , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Peptide Hydrolases/metabolism , Taste , Alcoholic Beverages/analysis , Esterification , Hydrolysis
2.
Biosci Biotechnol Biochem ; 83(2): 357-364, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30295131

ABSTRACT

Three new peptides: (pGlu)L-ethyl, (pGlu)LFGP-ethyl and (pGlu)LFNP-ethyl, were identified in the search for pyroglutamyl oligopeptide ethyl esters in sake. The ethyl esterified peptides in sake were quantitated using stable isotope dilution analysis and additional quantitation of (pGlu)L was performed using an external standard method. The concentrations of (pGlu)L-ethyl and (pGlu)L in 33 commercial sake samples ranged from 0.16 to 1.57 mg/L and 1.49 to 7.55 mg/L, respectively. The sensory properties of the pyroglutamyl oligopeptide ethyl esters and corresponding non-esterified peptides were examined: the estimated difference threshold of (pGlu)L (2.0 mg/L) and (pGlu)L-ethyl (0.267 mg/L) was exceeded in 32 and 26 samples, respectively. Estimated thresholds of (pGlu)LFGP-ethyl and (pGlu)LFNP-ethyl were often lower than the levels in quantitated sake samples. The sensory effects of these pyroglutamyl dipeptides on a model sake quality may be negative because of their unpleasant taste, however, (pGlu)LFNP-ethyl may be positive because of its mild taste.


Subject(s)
Alcoholic Beverages/analysis , Oligopeptides/analysis , Pyrrolidonecarboxylic Acid/chemistry , Chromatography, High Pressure Liquid , Limit of Detection , Pyrrolidonecarboxylic Acid/standards , Reference Standards , Spectrometry, Mass, Electrospray Ionization
3.
Chemistry ; 23(61): 15322-15326, 2017 Nov 02.
Article in English | MEDLINE | ID: mdl-28906573

ABSTRACT

A contracted doubly N-confused dioxohexaphyrin(1.1.1.1.1.0) complex consisting of two paramagnetic copper metals and open-shell π-radical ligand was synthesized as a new multi-heterospin motif. X-ray spectroscopy supported the divalent character of the inner copper centers, and electron paramagnetic resonance and magnetometric studies suggested the presence of unpaired d electrons strongly antiferromagnetically coupled with π-radicals delocalized on the macrocycle. The 25 π non-innocent dioxohexaphyrin ligand allowed the facile interconversion between antiaromatic 24 π and aromatic 26 π species, respectively, upon redox reactions.

4.
J Biol Chem ; 283(50): 34554-62, 2008 Dec 12.
Article in English | MEDLINE | ID: mdl-18940800

ABSTRACT

The metabolism of amyloid beta peptide (A beta) in the brain is crucial to the pathogenesis of Alzheimer disease. A body of evidence suggests that A beta is actively transported from brain parenchyma to blood across the blood-brain barrier (BBB), although the precise mechanism remains unclear. To unravel the cellular and molecular mechanism of A beta transport across the BBB, we established a new in vitro model of the initial internalization step of A beta transport using TR-BBB cells, a conditionally immortalized endothelial cell line from rat brain. We show that TR-BBB cells rapidly internalize A beta through a receptor-mediated mechanism. We also provide evidence that A beta internalization is mediated by LRP1 (low density lipoprotein receptor-related protein 1), since administration of LRP1 antagonist, receptor-associated protein, neutralizing antibody, or small interference RNAs all reduced A beta uptake. Despite the requirement of LRP1-dependent internalization, A beta does not directly bind to LRP1 in an in vitro binding assay. Unlike TR-BBB cells, mouse embryonic fibroblasts endogenously expressing functional LRP1 and exhibiting the authentic LRP1-mediated endocytosis (e.g. of tissue plasminogen activator) did not show rapid A beta uptake. Based on these data, we propose that the rapid LRP1-dependent internalization of A beta occurs under the BBB-specific cellular context and that TR-BBB is a useful tool for analyzing the molecular mechanism of the rapid transport of A beta across BBB.


Subject(s)
Amyloid beta-Peptides/chemistry , Blood-Brain Barrier , Gene Expression Regulation , Low Density Lipoprotein Receptor-Related Protein-1/physiology , Receptors, LDL/physiology , Tumor Suppressor Proteins/physiology , Amyloid beta-Peptides/pharmacokinetics , Animals , Brain/metabolism , Cell Line, Tumor , Collagen/metabolism , Fibroblasts/metabolism , Humans , In Vitro Techniques , Mice , Models, Biological , Protein Transport , Rats
6.
J Pharm Biomed Anal ; 43(5): 1769-74, 2007 Apr 11.
Article in English | MEDLINE | ID: mdl-17289324

ABSTRACT

A sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of valsartan in human plasma was developed and validated. A 0.5 ml aliquot was extracted using solid-phase extraction in an Empore high performance extraction disk plate, universal resin 96-well format. The estimated calibration range of the method was 2-2000 ng/ml. The method was fully validated with intra-day mean accuracy and precision of 94.8-107% and 2.19-5.40% and inter-day mean accuracy and precision of 93.5-105% and 1.87-5.67%, respectively. No significant loss of valsartan in processed samples was confirmed in processed samples for up to 24 h at 10 degrees C. Sample dilution up to 50-fold with blank human plasma provided acceptable analyses. No interference peaks or matrix effects were observed. No effect of QC sample location results was observed in a 96-well plate. This LC-MS/MS technique was found to improve quantitative determination of valsartan allowing its pharmacokinetic evaluation with clinically relevant doses.


Subject(s)
Antihypertensive Agents/blood , Antihypertensive Agents/pharmacokinetics , Chromatography, Liquid/methods , Tandem Mass Spectrometry/methods , Tetrazoles/blood , Tetrazoles/pharmacokinetics , Valine/analogs & derivatives , Antihypertensive Agents/chemistry , Drug Stability , Humans , Molecular Structure , Reference Standards , Reproducibility of Results , Sensitivity and Specificity , Temperature , Tetrazoles/chemistry , Valine/blood , Valine/chemistry , Valine/pharmacokinetics , Valsartan
7.
Rapid Commun Mass Spectrom ; 20(5): 733-40, 2006.
Article in English | MEDLINE | ID: mdl-16456806

ABSTRACT

We have developed a sensitive and specific liquid chromatography/mass spectrometry (LC/MS) method for the simultaneous determination of cyclosporine A (CsA) and its three main metabolites (AM1, AM4N and AM9) in human blood. Following protein precipitation, supernatant was directly injected into the LC/MS system. Chromatographic separation was accomplished on a Symmetry C8 (4.6 x 75 mm, 3.5 microm) column with a linear gradient elution prior to detection by atmospheric pressure chemical ionization (APCI) MS using selected ion monitoring (SIM) in positive mode. This method can be applied to single mass equipment. The analytical range for each analyte was set at 1-2500 ng/mL using 100 microL of blood sample. The analytical method was fully validated according to FDA guidance. Intra-day mean accuracy and precision were 95.2-113.5% and 0.9-8.9%, respectively. Inter-day mean accuracy and precision were 95.8-107.0% and 1.5-10.7%, respectively. In blood all analytes were stable during three freeze/thaw cycles, for 24 h at room temperature and for 12 months at or below -15 degrees C. Stability was also confirmed in processed samples for 24 h at 10 degrees C and for 6 months at 4 degrees C in methanol. In addition, we confirmed the method could avoid matrix effects from transplant subjects' samples. This LC/MS technique provided an excellent method for simultaneous quantitative determination of CsA and its three metabolites for evaluation of their pharmacokinetic profiles.


Subject(s)
Chromatography, High Pressure Liquid , Cyclosporine/blood , Immunosuppressive Agents/blood , Spectrometry, Mass, Electrospray Ionization/methods , Atmospheric Pressure , Cryopreservation , Cyclosporine/chemistry , Humans , Immunosuppressive Agents/chemistry , Male , Middle Aged , Reproducibility of Results
8.
J Pharm Biomed Anal ; 36(5): 1063-72, 2005 Jan 04.
Article in English | MEDLINE | ID: mdl-15620533

ABSTRACT

An assay based on cation exchange solid-phase extraction and liquid chromatography-tandem mass spectrometry (LC/MS/MS) has been developed for the quantitative determination of metformin in human plasma. The analytical method consists of cation exchange solid-phase extraction (VersaPlate CBA) without any further evaporation/dissolution steps and cation exchange-based HPLC separation (Capcell Pak SCX column) with a normal-phase gradient system followed by semi-micro LC/MS/MS in positive ion selected reaction monitoring mode using electrospray ionization. The method exhibited excellent performance in terms of selectivity, robustness, short run time (7 min/sample) and simplicity of sample preparation. The calibration range was 10-1000 ng/ml with 0.2 ml of plasma. Intra- and inter-day mean accuracies were within the ranges of 100.3-105.0% and 101.2-105.3%, respectively. Intra- and inter-day precisions were within the ranges of 0.8-1.9% and 1.5-8.6%, respectively. Mean absolute recovery was 67.0% for metformin. No apparent loss of metformin after extraction was observed in an autosampler at 10 degrees C for 24 h. Dilution of metformin by blank human plasma up to 20-fold was tested and revealed no impact on the results of determination. Furthermore, the method exhibited high selectivity, since no effect on metformin analysis was observed on comparison of samples with or without nateglinide and other agents in plasma. Results obtained with the method were also comparable to a published LC-UV method on cross-validation. This method can be applied to various clinical pharmacokinetic studies of metformin.


Subject(s)
Cation Exchange Resins/analysis , Metformin/blood , Chromatography, Liquid/methods , Humans , Mass Spectrometry/methods , Metformin/chemistry
9.
J Chromatogr B Analyt Technol Biomed Life Sci ; 802(2): 299-305, 2004 Apr 05.
Article in English | MEDLINE | ID: mdl-15018791

ABSTRACT

A simple and rapid assay is described for the simultaneous analysis of levodopa (l-DOPA) and 3-O-methyldopa (3-OMD) in human plasma samples, applying an ion-pair reversed-phase liquid chromatographic method with electrochemical detection, designed for clinical trials performed to study the effect of peripheral catechol-O-methyltransferase inhibitors on the metabolism of l-DOPA. After protein precipitation of 100 microl plasma sample aliquots with perchloric acid, the analytes are directly injected, separated within 10 min and simultaneously quantified down to 20 ng/ml by an electrochemical detector equipped with a dual-electrode system operating in redox mode eliminating effectively potential endogenous and exogenous interferences. The intra-assay precision for l-DOPA and 3-OMD was 1.34-6.54 and 3.90-5.50%, whereas the inter-assay precision was 2.09-7.69 and 4.16-9.90%, respectively. The recoveries were close to 90% for l-DOPA and almost 100% for 3-OMD. Satisfactory storage stability was achieved for up to 16 weeks at -70 degrees C by stabilizing plasma samples with antioxidants.


Subject(s)
Chromatography, High Pressure Liquid/methods , Electrochemistry/methods , Levodopa/blood , Tyrosine/analogs & derivatives , Tyrosine/blood , Calibration , Humans , Reference Standards , Reproducibility of Results , Sensitivity and Specificity
10.
Rapid Commun Mass Spectrom ; 18(4): 377-84, 2004.
Article in English | MEDLINE | ID: mdl-14966843

ABSTRACT

TCH346 (dibenzo[b,f]oxepin-10-ylmethyl-prop-2-ynylamine) is a novel propargylamine compound under investigation as a putative agent in the treatment of chronic neurodegenerative illnesses. To support clinical studies an analytical method was developed for TCH346 plus its three amine metabolites and a carboxylic acid metabolite in human plasma. Using a two-step liquid-liquid extraction, one under acidic and one under basic conditions, by pH-switching both the basic and acidic analytes were extracted from 0.5 mL of plasma. All these basic and acidic compounds could be analyzed simultaneously using gradient high-performance liquid chromatographic (HPLC) separation with positive/negative selected reaction monitoring mass spectrometry. As a result of the validation study, the analytical method was shown to be appropriate for the determination of TCH346 and its metabolites CGP70861, GP42120, CGP71090, and GP54840 in plasma for forthcoming clinical studies. The LLOQs were set to 2, 200, 20, 20, and 200 pg/mL for TCH346, CGP70861, GP42120, CGP71090, and GP54840, respectively, and the ULOQ for all analytes was 20 000 pg/mL. All analytes were stable in 50% MeOH at 4 degrees C for at least one year, in human plasma stored below -70 degrees C for at least 7 months, in human plasma below -18 degrees C for at least 6 months, in human plasma at room temperature for at least 1 day, and in the final extract solution at 4 degrees C for at least 3 days.


Subject(s)
Amines/blood , Amines/metabolism , Chromatography, High Pressure Liquid/methods , Mass Spectrometry/methods , Oxepins/blood , Oxepins/metabolism , Calibration , Humans , Molecular Structure , Reference Standards , Reproducibility of Results
11.
Histochem Cell Biol ; 117(3): 211-7, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11914918

ABSTRACT

Acyl-CoA hydrolases cleave acyl-CoA thioesters to free fatty acids and coenzyme A. The potency of these enzymes may serve to modulate cellular levels of acyl-CoAs to affect various cellular functions, including lipid metabolism. In this study, we investigated the tissue distribution of this multigene family of enzymes, focusing on cytosolic (CTE-I) and mitochondrial acyl-CoA thioesterases (MTE-I) in adult rats, using an anti-CTE-I antibody which recognizes both the isoforms. Western blotting detected them mainly in organs closely related to fatty acid oxidation, of which kidney contained the highest levels of both enzymes. Immunohistochemistry localized the enzymes primarily in the proximal tubules, where a large energy demand is expected and fatty acids represent a major fuel, correlating well with the intrarenal distribution of peroxisomal beta-oxidation. In situ hybridization suggested colocalization of CTE-I and MTE-I in the kidney. The immunoreactivity was also found in various epithelial tissues in the body, including Harderian gland and sebaceous gland. These results demonstrated the distribution of CTE-I and MTE-I in a wide variety of rat tissues, primarily characterized by an epithelial localization, being consistent with their involvement in fatty acid metabolism.


Subject(s)
Epithelium/enzymology , Multigene Family/genetics , Palmitoyl-CoA Hydrolase/metabolism , Adipose Tissue, Brown/enzymology , Animals , Blotting, Western , Brain/enzymology , Cytosol/enzymology , Immunohistochemistry , In Situ Hybridization , Kidney/enzymology , Liver/enzymology , Male , Mitochondria/enzymology , Myocardium/enzymology , Palmitoyl-CoA Hydrolase/genetics , Rats , Rats, Wistar , Testis/enzymology
12.
Brain Res Mol Brain Res ; 98(1-2): 81-92, 2002 Jan 31.
Article in English | MEDLINE | ID: mdl-11834298

ABSTRACT

Acyl-CoA hydrolase could provide a mechanism via its potency to modulate cellular concentrations of acyl-CoAs for the regulation of various cellular events including fatty acid metabolism and gene expression. However, only limited evidence of this is available. To better understand the physiological role of this enzyme, we characterized a mouse brain acyl-CoA hydrolase, mBACH. The cloned cDNA for mBACH encoded a 338-amino-acid polypeptide with >95% identity to the human and rat homologs, indicating that the BACH gene is highly conserved among species. This was supported by the similarity in genomic organization of the BACH gene between humans and mice. Bacterially expressed mBACH was highly active against long-chain acyl-CoAs with a relatively broad specificity for chain length. While palmitoyl-CoA hydrolase activity was widely distributed in mouse tissues, it was marked in the brain, consistent with mBACH being almost exclusively distributed in this tissue, where >80% of the enzyme activity was explained by mBACH present in the cytosol. Immunohistochemistry demonstrated a neuronal localization of mBACH in both the central and peripheral nervous systems. In neurons, mBACH was distributed throughout the cell body and neurites. Although four isoforms except mBACH itself, that may be generated by the alternative use of exons of a single mBACH gene, were cloned, their mRNA levels in the brain were estimated to be negligible. However, a 50-kDa polypeptide besides the major one of 43-kDa seemed to be translated from the mBACH mRNA with differential in-frame ATG triplets used as the initiation codon. These findings will contribute to the functional analysis of the BACH gene using mice including genetic studies.


Subject(s)
Cerebral Cortex/enzymology , Mice/genetics , Nerve Tissue Proteins/genetics , Palmitoyl-CoA Hydrolase/genetics , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Cerebral Cortex/cytology , Cloning, Molecular , Codon, Initiator/genetics , Cytosol/enzymology , DNA, Complementary/genetics , Exons/genetics , Female , Gonads/enzymology , Isoenzymes/genetics , Male , Mice, Inbred ICR , Molecular Sequence Data , Molecular Weight , Myocardium/enzymology , Nerve Tissue Proteins/physiology , Neurites/enzymology , Neuroblastoma/pathology , Organ Specificity , Palmitoyl-CoA Hydrolase/physiology , Recombinant Fusion Proteins/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Homology, Amino Acid , Species Specificity , Tumor Cells, Cultured , Viscera/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...